Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News PixarBio Corp PXRB

PixarBio Corporation is a specialty pharmaceutical company that is focused on the pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain. The Company’s lead product platform, NeuroRelease, is a novel biodegradable microparticle delivery system for the delivery of non-opiate prescription paid drugs. NeuroRelease offers sustained therapeutic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:PXRB)

The Rosen Law Firm, P.A. and The Brown Law Firm, P.C. Announce Proposed Class Action and Derivative Action Settlement on Behalf of Purchasers of PixarBio Corporation Securities -- PXRB

GlobeNewswire December 9, 2019

Robbins Arroyo LLP: PixarBio Corporation (PXRB) Misled Shareholders According to a Recently Filed Shareholder Derivative Lawsuit

Business Wire May 5, 2017

PixarBio Corporation’s CEO Frank Reynolds to Discuss Non-Opiate/Opioid NeuroRelease on the Pain and Addiction Panel at the 2017 MassBio Annual Meeting in Cambridge, MA on March 31, 2017

Business Wire March 30, 2017

PIXARBIO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against PixarBio Corporation – (PXRB)

Business Wire March 24, 2017

PXRB UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving PixarBio Corporation and a Lead Plaintiff Deadline of March 27, 2017

GlobeNewswire March 24, 2017

March 27 Deadline Alert: Law Offices of Howard G. Smith Reminds PixarBio Corporation Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm

Business Wire March 24, 2017

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PixarBio Corporation (PXRB) & Lead Plaintiff Deadline - March 27, 2017

GlobeNewswire March 24, 2017

Deadline Alert: GPM Reminds Investors of the March 27 Deadline in the Class Action Lawsuit Against PixarBio Corporation

Business Wire March 23, 2017

Block & Leviton Reminds PixarBio Corporation Investors Of Important Deadline In Securities Fraud Class Action

GlobeNewswire March 22, 2017

Opinion & Analysis (GREY:PXRB)

No current opinion is available.

Bullboard Posts (GREY:PXRB)